Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Solo again, Allergan strikes a $3.3B deal on Heptares' Alzheimer's portfolio
Solo again, Allergan strikes a $3.3B deal on Heptares' Alzheimer's portfolio
Solo again, Allergan strikes a $3.3B deal on Heptares' Alzheimer's portfolio
Submitted by
admin
on April 7, 2016 - 10:07am
Source:
Fierce Biotech
News Tags:
Allergan
Heptares Therapeutics
Alzheimer's disease
Headline:
Solo again, Allergan strikes a $3.3B deal on Heptares' Alzheimer's portfolio
Do Not Allow Advertisers to Use My Personal information
